Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel supported catalyst method improves yield and purity for folic acid production. Reduces reaction time and enhances supply chain reliability for global buyers.
Novel organofluorine-mediated synthesis of 2,3-unsaturated glycosides with high alpha-selectivity. Reduces heavy metal use and enables catalyst recycling for cost-effective API intermediate manufacturing.
Patent CN103435688A reveals a novel high-yield route for Phosphoramidone and Tarotide intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN105801337B details a novel Pd-Cu catalytic route for phenanthrene compounds offering high purity and scalable manufacturing for global supply chains.
Patent CN101514156A details high-gravity solvent recycling for Naproxen. Achieve cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Patent CN113652407B reveals a novel carbonyl reductase mutant enabling strict S-selectivity and enhanced activity for cost-effective chiral diol manufacturing.
Patent CN115772077B details Cu/AC catalytic conversion of arabitol. Offers high yield chiral intermediate for pharmaceutical manufacturing with cost efficiency.
Patent CN101337950A details a continuous glycerol hydrochlorination process for epichlorohydrin. This report analyzes the cost-effective, eco-friendly catalytic route for reliable supply chain integration.
Novel Filgotinib synthetic method offers high yield and simplified operation. Reliable supplier for pharmaceutical intermediates with cost-effective scale-up solutions.
Patent CN111705096A reveals enzymatic synthesis for high purity NMN. This method reduces solvent use and enhances supply chain stability for global pharmaceutical buyers.
Novel water-based method for allyl glycosides reduces cost and improves purity for pharmaceutical intermediates manufacturing.
Patent CN115043890A reveals water-based allylation. Reduces cost, improves beta-selectivity. Reliable supplier for pharma intermediates.
Patent CN111362999B details a novel oxidation method for Epristeride impurity. This report analyzes cost reduction in API manufacturing and high-purity reference standard production.
Patent CN109970568B reveals a room-temperature solid acid catalysis route for dimethyl 3-aminophthalate, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN102286030B details a novel L-lyxose synthesis route offering high purity and simplified operations for cost reduction in rare sugar manufacturing supply chains.
Patent CN105039450A reveals one-step enzymatic route. High purity, scalable process for reliable pharmaceutical intermediate supplier partners seeking significant cost reduction and efficiency.
Patent CN112573992A reveals a high-yield two-step route for halogenated cyclopropanes, offering cost-effective and scalable solutions for pharmaceutical and agrochemical manufacturing.
Patent CN118930491B reveals a novel [3+2] cycloaddition route for high-purity triazole intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Novel palladium-catalyzed route for high-purity epoxy nitriles enabling efficient furan intermediate manufacturing with reduced operational complexity.